Pulmonary Hypertension Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Bosentan in Patients With Mildly Symptomatic Pulmonary Arterial Hypertension (PAH)
| Verified date | August 2011 |
| Source | Actelion |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Food and Drug Administration |
| Study type | Interventional |
The present trial investigates a possible use of oral bosentan, which is currently approved for the treatment of symptoms of pulmonary arterial hypertension (PAH) Class III and IV, to patients suffering from PAH Class II.
| Status | Completed |
| Enrollment | 185 |
| Est. completion date | February 2011 |
| Est. primary completion date | November 2006 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 12 Years and older |
| Eligibility |
Inclusion Criteria: - PAH NYHA Class II - Significant elevation of mean pulmonary arterial pressure - Significant elevation of pulmonary vascular resistance at rest - Limited 6-minute walk distance Exclusion Criteria: - PAH secondary to portal hypertension, complex congenital heart disease or reverse shunt - Restrictive or obstructive lung disease - Significant vasoreactivity - Treatments for PAH (within 4 weeks of randomization) |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| Australia | The Prince Charles Hospital | Brisbane | |
| Australia | Royal Prince Albert Hospital | Camperdown | |
| Australia | St. Vincent's Hospital | Darlinghurst | |
| Austria | General Hospital of Vienna | Vienna | |
| Belgium | UZ Gasthuisberg | Leuven | |
| Canada | University of Calgary | Calgary | Alberta |
| Canada | University of Alberta | Edmonton | Alberta |
| Canada | Halifax Infirmary | Halifax | Nova Scotia |
| Canada | Victoria Medical Centre | Hamilton | Ontario |
| Canada | Centre de Pneumologie de L'Hospital Laval | Sainte Foy | Quebec |
| Canada | Toronto General Hospital | Toronto | Ontario |
| China | Queen Mary Hospital | Hong Kong | |
| Czech Republic | Interni klinika VFN | Prague | |
| France | Marseille-Timone | Marseille | |
| Germany | Universitat Greifswald | Greifswald | |
| Germany | Universitat Greifswald | Greifswald | |
| Germany | Universitarsklinikum Hamburg-Eppendorf | Hamburg | |
| Germany | Medizinische Universitatsklinik | Heidelberg | |
| Germany | Universitatsklinikim Leipzig | Leipzig | |
| Germany | Klinikum der Universitat Regensburg | Regensburg | |
| Italy | Policlinico S. Orsola-Malpighi | Bologna | |
| Netherlands | VU Medisch Centrum | Amsterdam | |
| Netherlands | University Hospital Maastricht | Maastricht | |
| Spain | Hospital Clinic | Barcelona | |
| Spain | Hospital Valle d'Hebron | Barcelona | |
| Spain | Hospital 12 de Octubre | Madrid | |
| Switzerland | Zurich University Hospital | Zurich | |
| United Kingdom | Papworth Hospital | Cambridge | |
| United States | University of Michigan | Ann Arbor | Michigan |
| United States | University of Alabama-Birmingham | Birmingham | Alabama |
| United States | Tufts- New England Medical Center | Boston | Massachusetts |
| United States | Cleveland Clinic Foundation | Cleveland | Ohio |
| United States | St. Paul University Hospital | Dallas | Texas |
| United States | Harbor UCLA Medical Center | Torrance | California |
| Lead Sponsor | Collaborator |
|---|---|
| Actelion |
United States, Australia, Austria, Belgium, Canada, China, Czech Republic, France, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | exercise capacity | Baseline to end of study | No | |
| Primary | cardiac hemodynamics | Baseline to end of study | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT01950585 -
Hydroxyurea in Pulmonary Arterial Hypertension
|
Early Phase 1 | |
| Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
| Completed |
NCT03649932 -
Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing
|
Phase 1 | |
| Recruiting |
NCT04554160 -
Arrhythmias in Pulmonary Hypertension Assessed by Continuous Long-term Cardiac Monitoring
|
||
| Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
| Completed |
NCT01894035 -
Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation
|
||
| Not yet recruiting |
NCT04083729 -
Persistent Pulmonary Hypertension After Percutaneous Mitral Commissurotomy
|
N/A | |
| Completed |
NCT02821156 -
Study on the Use of Inhaled NO (iNO)
|
N/A | |
| Completed |
NCT02216279 -
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension
|
Phase 2 | |
| Terminated |
NCT02243111 -
Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound
|
N/A | |
| Terminated |
NCT02246348 -
Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)
|
N/A | |
| Recruiting |
NCT01913847 -
Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
|
Phase 3 | |
| Completed |
NCT06240871 -
Contrast Enhanced PA Pressure Measurements
|
||
| Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
| Completed |
NCT02377934 -
Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study
|
||
| Recruiting |
NCT01091012 -
Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension
|
Phase 3 | |
| Completed |
NCT01463514 -
Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension
|
N/A | |
| Completed |
NCT00739375 -
The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension.
|
Phase 1 | |
| Completed |
NCT01484899 -
Smoking: a Risk Factor for Pulmonary Arterial Hypertension?
|
N/A | |
| Completed |
NCT02275793 -
The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure
|